#1 trading secret
He started as a janitor’s grandson… and ended up becoming a million dollar hedge fund insider... Now he’s revealing the #1 trading secret he learned during his time on Wall Street…
Continue Reading
pixel

GALT Insider Trading (Galectin Therapeutics)

Insider Ownership Percentage: 40.70%
Insider Buying (Last 12 Months): $23,050.00
Insider Selling (Last 12 Months): $201,900.00

Galectin Therapeutics Insider Trading History Chart

Galectin Therapeutics Share Price & Price History

$2.62
▲ +0.11 (4.38%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
100X Gains On Tap as Under-the-Radar Green-Tech Stock Soars
Searching for the next 1,000% stock winner? Look no further than key Green-Techs that are driving the EV, Solar & 5G booms. Silver is the #1 element in the Green Energy Revolution & we’ve found the top silver gem – undiscovered at 10-cents per share – that’s fueling the path to a carbon-free world.
Get the details here...
pixel

Galectin Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/5/2021Kevin D FreemanDirectorBuy5,000$2.04$10,200.0023,469  
4/1/2021Fund L.P. 10XMajor ShareholderSell10,000$2.16$21,600.00  
2/2/2021Fund L.P. 10XMajor ShareholderSell10,000$2.04$20,400.00  
1/11/2021Gilbert F AmelioDirectorSell60,000$2.17$130,200.0060,614  
10/13/2020Fund L.P. 10XMajor ShareholderSell10,000$2.97$29,700.00  
9/4/2020Kevin D FreemanDirectorBuy5,000$2.57$12,850.0023,469  
3/19/2020Kevin D FreemanDirectorBuy6,000$1.69$10,140.00
1/17/2020Fund L.P. 10XMajor ShareholderSell10,000$2.97$29,700.00  
11/15/2019Kevin D FreemanDirectorBuy3,000$3.36$10,080.0023,469  
10/10/2019Fund L.P. 10XMajor ShareholderSell17,000$3.73$63,410.00  
9/6/2019Kevin D FreemanDirectorBuy1,290$3.71$4,785.9023,469  
5/31/2019Jack W CallicuttCFOBuy2,354$4.28$10,075.123,614  
5/31/2019Richard E UihleinDirectorBuy4,680,606$4.28$20,032,993.683,128,489  
4/9/2019Richard E UihleinDirectorBuy20,700$4.82$99,774.002,628,489  
4/5/2019Kevin D FreemanDirectorBuy500$4.73$2,365.0022,043  
2/22/2019Marc RubinDirectorSell51,185$6.02$308,133.7013,581  
2/8/2019Kevin D FreemanDirectorBuy1,500$4.29$6,435.0022,043  
1/31/2019Gilbert F AmelioDirectorSell30,000$5.00$150,000.00  
1/29/2019Richard E UihleinDirectorBuy51,500$4.87$250,805.002,538,289  
9/25/2018Kary EldredDirectorBuy2,000$6.10$12,200.0041,382  
9/10/2018Gilbert S OmennDirectorSell19,370$6.02$116,607.4056,561  
9/7/2018Gilbert S OmennDirectorSell11,000$6.03$66,330.0056,561  
9/4/2018Marc RubinDirectorSell11,900$6.58$78,302.00  
8/30/2018Marc RubinDirectorSell58,100$6.08$353,248.0084,581  
6/25/2018Joel LewisDirectorBuy1,000$7.06$7,060.0051,480  
6/20/2018Jack W CallicuttCFOSell226,000$8.61$1,945,860.00103,993  
6/18/2018Fund L.P. 10XMajor ShareholderSell151,860$8.61$1,307,514.60  
6/18/2018James C CzirrDirectorSell60,000$9.06$543,600.00  
6/15/2018James C CzirrDirectorSell15,475$8.47$131,073.25  
6/14/2018Fund L.P. 10XMajor ShareholderSell76,385$8.28$632,467.80  
6/13/2018Harold H ShlevinCOOSell43,698$7.41$323,802.18  
6/13/2018James C CzirrDirectorSell208,140$7.17$1,492,363.80  
6/13/2018Peter G TraberCEOSell100,000$7.51$751,000.00207,333  
6/11/2018Harold H ShlevinCOOSell115,054$5.84$671,915.36103,914  
6/11/2018Jack W CallicuttCFOSell120,000$5.85$702,000.00101,260  
6/8/2018Jack W CallicuttCFOSell100,000$5.75$575,000.00101,260  
6/8/2018James C CzirrDirectorSell110,000$5.88$646,800.00  
6/8/2018Peter G TraberCEOSell70,000$5.86$410,200.00177,333  
6/7/2018Harold H ShlevinCOOSell109,969$5.20$571,838.8058,094  
6/5/2018Harold H ShlevinCOOSell20,831$5.15$107,279.6559,414  
6/4/2018Fund L.P. 10XMajor ShareholderSell50,000$5.12$256,000.00  
6/1/2018Harold H ShlevinCOOSell119,200$5.06$603,152.00103,914  
5/31/2018Jack W CallicuttCFOSell46,651$5.00$233,255.0047,911  
4/16/2018Theodore Daniel ZucconiDirectorSell4,000$3.58$14,320.005,083  
See Full Table

SEC Filings (Institutional Ownership Changes) for Galectin Therapeutics (NASDAQ:GALT)

17.58% of Galectin Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Galectin Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
3/2/2021FormulaFolio Investments LLC12,710$28K0.0%N/A0.022%
2/19/2021JPMorgan Chase & Co.103,713$0.23M0.0%+378.5%0.182%
2/12/2021Raymond James Financial Services Advisors Inc.18,229$41K0.0%N/A0.032%
2/11/2021Northern Trust Corp452,957$1.01M0.0%-2.8%0.794%
2/11/2021Barclays PLC12,006$27K0.0%-30.5%0.021%
2/10/2021Renaissance Technologies LLC15,627$35K0.0%N/A0.027%
2/10/2021D.A. Davidson & CO.767,321$1.72M0.0%-10.1%1.344%
2/9/2021Wells Fargo & Company MN96,815$0.22M0.0%+69.1%0.170%
2/5/2021BlackRock Inc.2,598,089$5.82M0.0%+3.8%4.552%
2/4/2021Cambridge Investment Research Advisors Inc.179,556$0.40M0.0%-6.1%0.315%
11/13/2020Morgan Stanley31,579$85K0.0%-51.6%0.055%
11/12/2020JPMorgan Chase & Co.21,674$72K0.0%-22.6%0.038%
11/10/2020State Street Corp698,113$1.86M0.0%+1.5%1.223%
11/9/2020The Manufacturers Life Insurance Company26,819$72K0.0%+23.4%0.047%
11/9/2020LPL Financial LLC18,584$50K0.0%-34.2%0.033%
11/6/2020BlackRock Inc.2,503,111$6.68M0.0%-0.4%4.385%
10/29/2020Cambridge Investment Research Advisors Inc.191,195$0.51M0.0%-5.8%0.335%
10/13/2020Brookstone Capital Management12,710$34K0.0%N/A0.022%
9/15/2020Two Sigma Advisers LP11,800$36K0.0%N/A0.021%
8/25/2020Nuveen Asset Management LLC181,943$0.56M0.0%+39.9%0.319%
8/14/2020Bank of America Corp DE10,895$33K0.0%+145.8%0.019%
8/14/2020Advisor Group Holdings Inc.1,012,430$3.10M0.0%+17.1%1.775%
8/13/2020Vivaldi Capital Management LLC15,439$40K0.0%+44.7%0.027%
8/12/2020Goldman Sachs Group Inc.20,794$64K0.0%+24.7%0.036%
7/31/2020UBS Group AG12,401$38K0.0%-50.4%0.022%
6/19/2020State Street Corp663,783$1.30M0.0%-1.1%1.164%
5/18/2020Advisor Group Holdings Inc.864,275$1.69M0.0%N/A1.515%
5/15/2020Morgan Stanley55,511$0.11M0.0%-66.1%0.097%
5/15/2020Two Sigma Investments LP16,932$33K0.0%N/A0.030%
5/14/2020Wells Fargo & Company MN45,658$89K0.0%+45.1%0.080%
5/14/2020Geode Capital Management LLC561,368$1.10M0.0%+3.1%0.984%
5/14/2020Deutsche Bank AG13,826$28K0.0%-35.1%0.024%
5/14/2020MML Investors Services LLC28,541$56K0.0%+28.9%0.050%
5/14/2020Nuveen Asset Management LLC130,022$0.26M0.0%+21.2%0.228%
5/12/2020JPMorgan Chase & Co.40,599$79K0.0%+209.2%0.071%
5/11/2020State Street Corp663,783$1.30M0.0%-1.1%1.164%
5/8/2020Cambridge Investment Research Advisors Inc.204,824$0.40M0.0%+7.4%0.359%
5/2/2020SG Americas Securities LLC12,876$25K0.0%N/A0.023%
5/1/2020BlackRock Inc.2,553,541$5.01M0.0%-1.1%4.477%
5/1/2020UBS Group AG25,009$49K0.0%-51.3%0.044%
3/5/2020Nuveen Asset Management LLC107,272$0.31M0.0%-12.2%0.189%
2/20/2020Geode Capital Management LLC544,573$1.56M0.0%+15.7%0.957%
2/18/2020Ameritas Investment Company LLC10,782$31K0.0%N/A0.019%
2/14/2020Goldman Sachs Group Inc.32,076$92K0.0%-22.9%0.056%
2/14/2020UBS Group AG51,319$0.15M0.0%+53.5%0.090%
2/13/2020Oxford Asset Management LLP27,906$80K0.0%N/A0.049%
2/13/2020Renaissance Technologies LLC39,100$0.11M0.0%N/A0.069%
2/12/2020Advisor Group Inc.799,846$2.29M0.0%+3.0%1.406%
2/10/2020Barclays PLC40,060$0.12M0.0%+101.6%0.070%
2/6/2020State Street Corp671,117$1.92M0.0%+20.7%1.180%
2/4/2020Virtu Financial LLC54,738$0.16M0.0%N/A0.096%
2/4/2020Cambridge Investment Research Advisors Inc.190,680$0.55M0.0%-18.4%0.335%
11/27/2019Millennium Management LLC10,161$37K0.0%-91.5%0.018%
11/27/2019Squarepoint Ops LLC13,901$51K0.0%+37.5%0.024%
11/27/2019California State Teachers Retirement System62,417$0.23M0.0%+25.7%0.110%
11/27/2019State Street Corp556,124$2.04M0.0%+7.9%0.978%
11/5/2019D.A. Davidson & CO.820,158$3.01M0.1%+3.7%1.444%
10/17/2019Wedbush Securities Inc.21,498$79K0.0%-12.2%0.038%
8/20/2019Amussen Hunsaker Associates LLC17,090$71K0.0%N/A0.030%
8/15/2019Cambridge Investment Research Advisors Inc.232,554$0.97M0.0%+32.0%0.411%
8/15/2019Centaurus Financial Inc.16,563$69K0.0%+20,098.8%0.029%
8/14/2019D. E. Shaw & Co. Inc.19,498$81K0.0%+19.3%0.034%
8/14/2019Vivaldi Capital Management LLC10,668$44K0.0%N/A0.019%
8/14/2019Morgan Stanley53,645$0.22M0.0%-9.0%0.095%
8/14/2019Vanguard Group Inc.1,734,324$7.20M0.0%+7.8%3.804%
8/13/2019BlackRock Inc.2,045,111$8.49M0.0%+243.4%4.485%
8/13/2019MML Investors Services LLC28,793$0.12M0.0%+38.5%0.063%
8/13/2019D.A. Davidson & CO.790,874$3.28M0.1%+4.8%1.735%
8/13/2019Northern Trust Corp134,116$0.56M0.0%+49.4%0.294%
8/12/2019Bank of New York Mellon Corp95,315$0.40M0.0%+392.5%0.209%
8/12/2019BT Wealth Management LLC57,009$0.19M0.1%+14.0%0.125%
8/10/2019Charles Schwab Investment Management Inc.75,092$0.31M0.0%N/A0.165%
8/1/2019Wedbush Securities Inc.24,498$0.10M0.0%+36.1%0.054%
7/31/2019Cutter & CO Brokerage Inc.89,240$0.37M0.1%N/A0.196%
7/31/2019Advisor Group Inc.807,175$3.35M0.0%+16.5%1.771%
6/30/2019Commonwealth Equity Services LLC15,247$63K0.0%+25.1%0.033%
6/30/2019WINTON GROUP Ltd40,279$0.17M0.0%+37.5%0.088%
6/16/2019Belpointe Asset Management LLC26,998$0.14M0.0%N/A0.059%
5/10/2019Alpine Global Management LLC19,093$98K0.0%-18.2%0.042%
5/9/2019Advisor Group Inc.692,589$3.54M0.0%+2.7%1.521%
5/8/2019Cambridge Investment Research Advisors Inc.176,222$0.90M0.0%N/A0.387%
5/8/2019Laurion Capital Management LP171,543$0.88M0.0%+81.7%0.377%
4/4/2019Tibra Equities Europe Ltd72,685$0.37M0.0%N/A0.160%
2/15/2019BT Wealth Management LLC50,000$0.25M0.1%N/A0.122%
2/15/2019Cetera Advisor Networks LLC19,021$66K0.0%-43.6%0.046%
2/14/2019MML Investors Services LLC26,926$92K0.0%+55.8%0.065%
2/14/2019First Foundation Advisors18,240$63K0.0%-92.6%0.044%
2/14/2019Barclays PLC174,603$0.60M0.0%+2,711.6%0.424%
2/13/2019Geode Capital Management LLC227,175$0.78M0.0%+7.3%0.552%
2/11/2019Advisor Group Inc.674,291$2.31M0.0%+12.8%1.639%
2/8/2019BlackRock Inc.604,268$2.07M0.0%+0.4%1.469%
2/8/2019Stratos Wealth Partners LTD.40,950$0.14M0.0%+45.5%0.100%
1/29/2019D.A. Davidson & CO.718,923$2.47M0.0%+4.3%1.748%
12/13/2018Vanguard Group Inc1,432,576$8.61M0.0%+18.7%3.482%
11/23/2018Belpointe Asset Management LLC31,129$0.19M0.0%-28.5%0.076%
11/23/2018Vanguard Group Inc.1,432,576$8.61M0.0%+18.7%3.482%
11/13/2018First Foundation Advisors245,740$1.48M0.1%N/A0.601%
11/13/2018Monashee Investment Management LLC65,056$0.39M0.1%N/A0.159%
11/13/2018Virtu Financial LLC17,752$0.11M0.0%N/A0.043%
11/13/2018D.A. Davidson & CO.689,278$4.14M0.1%+5.0%1.685%
Data available starting January 2016

See Full Table
Galectin Therapeutics logo
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is (GR-MD-02) belapectin galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Read More

Today's Range

Now: $2.62
$2.46
$2.75

50 Day Range

MA: $2.26
$2.03
$2.80

52 Week Range

Now: $2.62
$1.65
$3.85

Volume

598,105 shs

Average Volume

602,928 shs

Market Capitalization

$149.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.04

Who are the company insiders with the largest holdings of Galectin Therapeutics?

Galectin Therapeutics' top insider investors include:
  1. Richard E Uihlein (Director)
  2. Gilbert F Amelio (Director)
  3. Kevin D Freeman (Director)
  4. Jack W Callicutt (CFO)
  5. Fund LP 10X (Major Shareholder)
Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video)
"Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project…

What happens next will shock you…"
Click here to see what happened.